Predicting interactions between T cell receptors and MHC-peptide complexes

Molecular Immunology

Volumn 48, Issue 4, 2011, Pages 553-562

  Roomp, Kirsten ^a   Domingues, Francisco S ^a  

^a MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

Author keywords

MHC peptide complex; Non covalent interactions; Protein interface; Residue interaction prediction; T cell receptor

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR;

ARTICLE; COMPLEMENTARITY DETERMINING REGION; CRYSTAL STRUCTURE; MAJOR HISTOCOMPATIBILITY COMPLEX; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN STRUCTURE; X RAY CRYSTALLOGRAPHY;

ALGORITHMS; AMINO ACID SEQUENCE; ANIMALS; CRYSTALLOGRAPHY, X-RAY; HISTOCOMPATIBILITY ANTIGENS; HLA-A ANTIGENS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, ANTIGEN, T-CELL;

EID: 78650590064     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.10.014     Document Type: Article

References (47)

1. Arden B., Clark S.P., Kabelitz D., Mak T.W. Human T-cell receptor variable gene segment families. Immunogenetics 1995, 42:455-500.
2. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E. The Protein Data Bank. Nucleic Acids Res. 2000, 28:235-242.
3. Buslepp J., Wang H., Biddison W.E., Appella E., Collins E.J. A correlation between TCR Valpha docking on MHC and CD8 dependence: implications for T cell selection. Immunity 2003, 19:595-606.
4. Buus S., Lauemoller S.L., Worning P., Kesmir C., Frimurer T., Corbet S., Fomsgaard A., Hilden J., Holm A., Brunak S. Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens 2003, 62:378-384.
5. Chao D.L., Davenport M.P., Forrest S., Perelson A.S. The effects of thymic selection on the range of T cell cross-reactivity. Eur. J. Immunol. 2005, 35:3452-3459.
6. Chen J.L., Stewart-Jones G., Bossi G., Lissin N.M., Wooldridge L., Choi E.M., Held G., Dunbar P.R., Esnouf R.M., Sami M., Boulter J.M., Rizkallah P., Renner C., Sewell A., van der Merwe P.A., Jakobsen B.K., Griffiths G., Jones E.Y., Cerundolo V. Structural and kinetic basis for heightened immunogenicity of T cell vaccines. J. Exp. Med. 2005, 201:1243-1255.
7. Cole D.K., Yuan F., Rizkallah P.J., Miles J.J., Gostick E., Price D.A., Gao G.F., Jakobsen B.K., Sewell A.K. Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor. J. Biol. Chem. 2009, 284:27281-27289.
8. Detours V., Mehr R., Perelson A.S. A quantitative theory of affinity-driven T cell repertoire selection. J. Theor. Biol. 1999, 200:389-403.
9. Detours V., Perelson A.S. Explaining high alloreactivity as a quantitative consequence of affinity-driven thymocyte selection. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:5153-5158.
10. Ding Y.H., Smith K.J., Garboczi D.N., Utz U., Biddison W.E., Wiley D.C. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity 1998, 8:403-411.
11. Falk K., Rotzschke O., Stevanovic S., Jung G., Rammensee H.G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991, 351:290-296.
12. Fawcett, T., 2004. ROC graphs: notes and practical considerations for researchers. Technical Report HPL-2003-4.
13. Garboczi D.N., Ghosh P., Utz U., Fan Q.R., Biddison W.E., Wiley D.C. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 1996, 384:134-141.
14. Garcia K.C., Adams J.J., Feng D., Ely L.K. The molecular basis of TCR germline bias for MHC is surprisingly simple. Nat. Immunol. 2009, 10:143-147.
15. Gras S., Saulquin X., Reiser J.B., Debeaupuis E., Echasserieau K., Kissenpfennig A., Legoux F., Chouquet A., Le Gorrec M., Machillot P., Neveu B., Thielens N., Malissen B., Bonneville M., Housset D. Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope. J. Immunol. 2009, 183:430-437.
16. Humphrey W., Dalke A., Schulten K. VMD: visual molecular dynamics. J. Mol. Graph. 1996, 14:33-38. 27-8.
17. Kaas Q., Ruiz M., Lefranc M.P. IMGT/3Dstructure-DB and IMGT/StructuralQuery, a database and a tool for immunoglobulin, T cell receptor and MHC structural data. Nucleic Acids Res. 2004, 32:D208-D210.
18. Kosmrlj A., Chakraborty A.K., Kardar M., Shakhnovich E.I. Thymic selection of T-cell receptors as an extreme value problem. Phys. Rev. Lett. 2009, 103:068103.
19. Kosmrlj A., Jha A.K., Huseby E.S., Kardar M., Chakraborty A.K. How the thymus designs antigen-specific and self-tolerant T cell receptor sequences. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:16671-16676.
20. Kosmrlj A., Read E.L., Qi Y., Allen T.M., Altfeld M., Deeks S.G., Pereyra F., Carrington M., Walker B.D., Chakraborty A.K. Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection. Nature 2010, 465:350-354.
21. Lafuente E.M., Reche P.A. Prediction of MHC-peptide binding: a systematic and comprehensive overview. Curr. Pharm. Des. 2009, 15:3209-3220.
22. Liang X., Weigand L.U., Schuster I.G., Eppinger E., van der Griendt J.C., Schub A., Leisegang M., Sommermeyer D., Anderl F., Han Y., Ellwart J., Moosmann A., Busch D.H., Uckert W., Peschel C., Krackhardt A.M. A single TCR alpha-chain with dominant peptide recognition in the allorestricted HER2/neu-specific T cell repertoire. J. Immunol. 2010, 184:1617-1629.
23. Lin H.H., Ray S., Tongchusak S., Reinherz E.L., Brusic V. Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research. BMC Immunol. 2008, 9:8.
24. Lundegaard C., Lamberth K., Harndahl M., Buus S., Lund O., Nielsen M. NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Res. 2008, 36:W509-W512.
25. Marrack P., Scott-Browne J.P., Dai S., Gapin L., Kappler J.W. Evolutionarily conserved amino acids that control TCR-MHC interaction. Annu. Rev. Immunol. 2008, 26:171-203.
26. Menke M., Berger B., Cowen L. Matt: local flexibility aids protein multiple structure alignment. PLoS Comput. Biol. 2008, 4:e10.
27. Morgan R.A., Dudley M.E., Yu Y.Y., Zheng Z., Robbins P.F., Theoret M.R., Wunderlich J.R., Hughes M.S., Restifo N.P., Rosenberg S.A. High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens. J. Immunol. 2003, 171:3287-3295.
28. Moss P.A., Moots R.J., Rosenberg W.M., Rowland-Jones S.J., Bodmer H.C., McMichael A.J., Bell J.I. Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:8987-8990.
29. Nielsen M., Lundegaard C., Worning P., Lauemoller S.L., Lamberth K., Buus S., Brunak S., Lund O. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Prot. Sci. 2003, 12:1007-1017.
30. Player M.A., Barracchini K.C., Simonis T.B., Rivoltini L., Arienti F., Castelli C., Mazzocchi A., Belli F., Parmiani G., Marincola F.M. Differences in frequency distribution of HLA-A2 subtypes between North American and Italian white melanoma patients: relevance for epitope specific vaccination protocols. J. Immunother. Emphasis Tumor Immunol. 1996, 19:357-363.
31. Reichmann D., Rahat O., Cohen M., Neuvirth H., Schreiber G. The molecular architecture of protein-protein binding sites. Curr. Opin. Struct. Biol. 2007, 17:67-76.
32. Roomp K., Antes I., Lengauer T. Predicting MHC class I epitopes in large datasets. BMC Bioinform. 2010, 11:90.
33. Rudolph M.G., Stanfield R.L., Wilson I.A. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 2006, 24:419-466.
34. Ruppert J., Sidney J., Celis E., Kubo R.T., Grey H.M., Sette A. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 1993, 74:929-937.
35. Schub A., Schuster I.G., Hammerschmidt W., Moosmann A. CMV-specific TCR-transgenic T cells for immunotherapy. J. Immunol. 2009, 183:6819-6830.
36. Schuster I.G., Busch D.H., Eppinger E., Kremmer E., Milosevic S., Hennard C., Kuttler C., Ellwart J.W., Frankenberger B., Nossner E., Salat C., Bogner C., Borkhardt A., Kolb H.J., Krackhardt A.M. Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies. Blood 2007, 110:2931-2939.
37. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13:2498-2504.
38. Shatsky M., Nussinov R., Wolfson H.J. A method for simultaneous alignment of multiple protein structures. Proteins 2004, 56:143-156.
39. Shieh D.C., Lin D.T., Yang B.S., Kuan H.L., Kao K.J. High frequency of HLA-A*0207 subtype in Chinese population. Transfusion 1996, 36:818-821.
40. Stewart-Jones G.B., McMichael A.J., Bell J.I., Stuart D.I., Jones E.Y. A structural basis for immunodominant human T cell receptor recognition. Nat. Immunol. 2003, 4:657-663.
41. Swets J.A. Measuring the accuracy of diagnostic systems. Science 1988, 240:1285-1293.
42. Team R.D.C. R Reference Manual: Base Package. Network Theory 2003.
43. Vita R., Zarebski L., Greenbaum J.A., Emami H., Hoof I., Salimi N., Damle R., Sette A., Peters B. The Immune Epitope Database 2.0. Nucleic Acids Res. 2010, 38:D854-D862.
44. Word J.M., Lovell S.C., LaBean T.H., Taylor H.C., Zalis M.E., Presley B.K., Richardson J.S., Richardson D.C. Visualizing and quantifying molecular goodness-of-fit: small-probe contact dots with explicit hydrogen atoms. J. Mol. Biol. 1999, 285:1711-1733.
45. Word J.M., Lovell S.C., Richardson J.S., Richardson D.C. Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation. J. Mol. Biol. 1999, 285:1735-1747.
46. Yewdell J.W., Bennink J.R. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 1999, 17:51-88.
47. Zhang H., Lundegaard C., Nielsen M. Pan-specific MHC class I predictors: a benchmark of HLA class I pan-specific prediction methods. Bioinformatics 2009, 25:83-89.